PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17009102-5	2007	RESULTS: The reverse-charge mutants R282D-hPepT1 and D341R-hPepT1 showed significantly reduced gly-sar uptake, but the double mutant (R282D/D341R-hPepT1) has functionality comparable to that of wild-type hPepT1.	Glycine	95-98	solute carrier family 15 member 1	Homo sapiens	42-48	
17009102-5	2007	RESULTS: The reverse-charge mutants R282D-hPepT1 and D341R-hPepT1 showed significantly reduced gly-sar uptake, but the double mutant (R282D/D341R-hPepT1) has functionality comparable to that of wild-type hPepT1.	Glycine	95-98	solute carrier family 15 member 1	Homo sapiens	59-65	
17009102-5	2007	RESULTS: The reverse-charge mutants R282D-hPepT1 and D341R-hPepT1 showed significantly reduced gly-sar uptake, but the double mutant (R282D/D341R-hPepT1) has functionality comparable to that of wild-type hPepT1.	Glycine	95-98	solute carrier family 15 member 1	Homo sapiens	59-65	
17009102-5	2007	RESULTS: The reverse-charge mutants R282D-hPepT1 and D341R-hPepT1 showed significantly reduced gly-sar uptake, but the double mutant (R282D/D341R-hPepT1) has functionality comparable to that of wild-type hPepT1.	Glycine	95-98	solute carrier family 15 member 1	Homo sapiens	59-65	
17009102-6	2007	Gly-sar uptake by R282C-hPepT1 is reduced, but pre-incubation with 1 mM MTSET, a positively charged cysteine-modifying reagent, restored function to wild-type levels.	Glycine	0-3	solute carrier family 15 member 1	Homo sapiens	24-30	
17009102-7	2007	Similarly, pre-incubation of D341C-hPepT1 with 10 mM MTSES, a negatively charged cysteine-modifying reagent, increased gly-sar uptake compared to unmodified D341C-hPepT1.	Glycine	119-122	solute carrier family 15 member 1	Homo sapiens	35-41	
17009102-8	2007	In contrast, MTSET modification of D341C-hPepT1 (giving a positive charge at position 341) resulted in significant reduction in gly-sar uptake, compared to D341C-hPepT1.	Glycine	128-131	solute carrier family 15 member 1	Homo sapiens	41-47